CAS: 117570-53-3 - 5,6-Dimethylxantheonone-4-acetic acid

Fórmula: C₁₇H₁₄O₄

InChI: InChI=1S/C17H14O4/c1-9-6-7-13-15(20)12-5-3-4-11(8-14(18)19)17(12)21-16(13)10(9)2/h3-7H,8H2,1-2H3,(H,18,19)

Chave InChI: InChIKey=XGOYIMQSIKSOBS-UHFFFAOYSA-N

SMILES: O=C(O)CC=1C=CC=C2C(=O)C3=CC=C(C(=C3OC21)C)C

Sinónimos:

• (5,6-Dimethyl-9-Oxo-Xanthen)-4-Acetic Acid
• (5,6-dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid
• 2-(5,6-Dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid
• 2-(5,6-Dimethyl-9-oxoxanthen-4-yl)acetic acid
• 5,6-Dimethyl-9-oxo-9H-xanthen-4-ylacetic acid
• 5,6-Dimethyl-9-oxo-9H-xanthene-4-acetic acid
• 5,6-Dimethylxanthenone-4-acetic acid
• 5,6-Dimethylxanthenoneacetic Acid
• 9H-Xanthene-4-acetic acid, 5,6-dimethyl-9-oxo-
• As 1404
• Asa 404
• D5817
• Dmxaa
• NSC 640488
• Vadimezan

Vadimezan

CAS: 117570-53-3

• Fórmula: C₁₇H₁₄O₄
• Pureza: >98.0%(HPLC)
• Cor e Forma: White to Light yellow powder to crystal
• Peso molecular: 282.30

9H-Xanthene-4-aceticacid, 5,6-dimethyl-9-oxo-

CAS: 117570-53-3

• Fórmula: C₁₇H₁₄O₄
• Pureza: 97%
• Cor e Forma: Solid
• Peso molecular: 282.2907

Vadimezan

CAS: 117570-53-3

Vadimezan (NSC 640488) is a fused tricyclic analogue of flavone acetic acid with potential antineoplastic …

• Fórmula: C₁₇H₁₄O₄
• Pureza: 97.38% - ≥98%
• Cor e Forma: Solid
• Peso molecular: 282.29

Vadimezan

CAS: 117570-53-3

• Fórmula: C₁₇H₁₄O₄
• Pureza: (HPLC) ≥ 98.0%
• Cor e Forma: White to light yellow or light brown crystalline powder
• Peso molecular: 282.29

(5,6-Dimethyl-9-oxo-xanthen)-4-acetic acid

CAS: 117570-53-3

• Pureza: 95.0%
• Cor e Forma: Solid
• Peso molecular: 282.2950134277344

Vadimezan

CAS: 117570-53-3

Tumour vascular disrupting agent acting through targeting the STING pathway

• Fórmula: C₁₇H₁₄O₄
• Pureza: Min. 95%
• Cor e Forma: Powder
• Peso molecular: 282.29 g/mol

Vadimezan

CAS: 117570-53-3

Applications Vadimezan is a drug that displayed vascular-disrupting activity and induced haemorrhagic necrosis and tumour …

• Fórmula: C₁₇H₁₄O₄
• Cor e Forma: Neat
• Peso molecular: 282.29